Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LifeStance Health Gr Sees Q4 Sales $368.000M-$388.000M vs $379.839M Est

Author: Benzinga Newsdesk | November 06, 2025 06:05am
LifeStance Health Gr (NASDAQ:LFST) sees Q4 sales of $368.000 million-$388.000 million vs $379.839 million analyst estimate.

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist